Sort:
Date
Filter:
All

3,646 result(s) found

GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares https://www.rttnews.com/story.aspx?Id=3509593 Feb 05, 2025 - Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, after the British drug maker reported Wednesday a higher fourth-quarter results and issued positive outlook for fiscal 2025. The company further raised its sales view for fiscal 2031, and announced dividends and 2 billion pounds share buyback programme.
Fast fashion, laptops and toys are likely to cost more due to US tariffs on Chinese imports https://www.sandiegouniontribune.com/2025/02/05/trump-tariffs-consumer-products/ Feb 05, 2025 - An additional 10% tariff on all Chinese goods is likely drive up prices for some apparel, toys and electronic devices.
Estee Lauder to cut up to 7,000 jobs as sales slide https://www.sandiegouniontribune.com/2025/02/04/estee-lauder-job-cuts/ Feb 04, 2025 - Estee Lauder may trim more than 11% of its workforce.
HR unicorn Deel prepares for IPO as soon as 2026 after revenue jump https://www.cnbc.com/2025/02/04/hr-unicorn-deel-prepares-for-ipo-as-soon-as-2026.html Feb 04, 2025 - Human resources software firm Deel said it has hit an annual revenue run rate of $800 million as it ramps up preparations to go public.
UBS Turns To Profit In Q4, Hikes Dividend, Plans $3 Bln Buyback; But Stock Down https://www.rttnews.com/story.aspx?Id=3509008 Feb 04, 2025 - Swiss banking major UBS Group AG reported Tuesday a profit in its fourth quarter, compared to prior year's loss, benefited by increased revenues. The company also raised its dividend, and announced up to $3 billion share buyback program. Meanwhile, the shares were losing around 5 percent in the trading in Switzerland, as well as around 6 percent in pre-market activity on the NYSE.
UBS shares retreat 6% as fourth-quarter profit beat, $3 billion buyback fail to impress https://www.cnbc.com/2025/02/04/ubs-earnings-q4-2024.html Feb 04, 2025 - UBS revealed plans for up to $3 billion of share repurchases over the course of 2025.
As markets absorb tariff news, it's a wake-up call for individual investors, experts say https://www.cnbc.com/2025/02/03/as-markets-absorb-tariff-news-its-a-wake-up-call-for-investors-experts.html Feb 03, 2025 - Plans for new tariffs on Canada and China and Mexico sent stocks falling early Monday. Even as markets recover, experts say it's a wake-up call for investors.
As markets buckle up for Trump tariffs, these global sectors brace for a rough ride https://www.cnbc.com/2025/02/03/global-sectors-most-impacted-trump-tariffs.html Feb 03, 2025 - U.S. President Donald Trump has jolted global markets with an earlier-than-expected and stringent implementation of tariffs on China, Canada and Mexico.
Stellantis Changes Management, Structure; Searching For CEO; Stock Dips https://www.rttnews.com/story.aspx?Id=3508543 Feb 03, 2025 - Stellantis N.V. Monday announced a further shake-up in its management and structure following the ouster of Chief Executive Officer Carlos Tavares in December amid different views about the auto major. The company said the process to appoint a new permanent Chief Executive Officer is well underway, expected within the first half of 2025.
HCW Biologics Gets Clearance Form FDA To Initiate Phase 1 Study Of HCW9302 In Alopecia Areata https://www.rttnews.com/story.aspx?Id=3508505 Feb 03, 2025 - HCW Biologics Inc. (HCWB) a clinical-stage biopharmaceutical company, Monday said that the Food and Drug Administration (FDA)has given clearance to initiate a Phase 1 study of its lead drug candidate HCW9302, in patients with alopecia areata, an autoimmune disease that causes hair loss. The company's shares were more than 175 percent up in pre-market.

Pages: 1...3839404142434445464748...365

<<<Page 43>